Subscribe to our Newsletters !!
Few developments in science and technology have be
Biotech Fluidics offers a range of non-invasive fl
The recent rabies death of an 11 year old Canadian
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Micro
The pharmaceutical sector is transforming rapidly. Resulting from this transformation, analytical labs will likely need to provide results that are faster, more accurate, and more reproducible. Ranging from small molecules to biologics, cell therapies, gene therapies, and tailored medicines, modern pharmaceutical products require advanced analytical technologies and sophisticated methods that can detect even the smallest changes in the quality of pharmaceutical products.
“In today’s pharmaceutical landscape, quality is no longer just a regulatory requirement—it is a strategic advantage driven by precision, innovation, and intelligent analytical science.”
Contemporary pharmaceutical analytical laboratories have even gone beyond traditional roles. These laboratories have become centers for innovations. The convergence of advanced instruments, automated processes, artificial intelligence, and digital data have made it possible to construct laboratories where the highest standards of safety, efficacy, and compliance with the regulations are built into each product.
The future of pharmaceutical analytical technologies is transforming the measurement, monitoring, and maintenance of quality during the entire life cycle of the pharmaceutical product. The innovations will allow pharmaceutical companies to achieve a high quality product while improving the speed of product development and the efficiency of operations.
Quality is the most important aspect of pharmaceutical product manufacturing, and while this continues to be the case, the significance of quality in the recent years is rapidly evolving.
Regulatory authorities expect organizations to have a deep understanding of their products and processes. This understanding is to be verified by robust scientific evidence and is to be accompanied by continuous oversight.
Manufacturers are beginning to incorporate quality into the manufacturing process, rather than just assessing the quality of the final product.
Current pharmaceutical labs are built around cutting edge sophisticated analytical tools that enable them to create and collect highly accurate data and produce highly reproducible results.
Pharmaceutical Quality Assurance technologies assess a range of products from identity to unstable, to pure and contaminated, to stable.
See Beyond the Ordinary High-Resolution Mass Spectrometry (HRMS) has revolutionized an entire industry.
Now, laboratories use HRMS to determine the quality of a product to a greater extent by detecting, for example, impurities or degradation.
Because of how sensitive HRMS is, it is a great tool for ensuring safety and supporting regulations, while also improving and expediting the pharmaceutical development process.
One of the most significant changes in the industry was the shift from testing the end product to analyzing processes as they occur.
With Process Analytical Technology (PAT), companies can analyze the important parameters of the production process as it is being completed.
Because PAT analyzes processes in real-time, it is possible and common for the production process to be modified to eliminate wasted resources from the process and to reduce the number of failed batches. Additionally, PAT helps improve the consistency of the production process.
Many modern laboratories analyze tens of thousands of samples weekly. As a result, labs are becoming more efficient with:
Because automation minimizes the need for human involvement, reproducibility is also improved. Scientists can also spend more time analyzing results, rather than preparing samples and completing other routine lab tasks.
AI is now an integral part of pharmaceutical analytical science.
AI is even capable of performing chromatographic peak integration, spectral interpretation, and method optimization. One of the greatest impacts of AI in laboratories will be the improvement of quality assurance.
Laboratories are becoming more digital and connected. Consequently, systems that were once based on paper documents are becoming integrated systems that are secure and digital.
Because modern digital systems eliminate the need to record results by hand, they reduce errors and facilitate a complete audit of results.
Digital systems of record comply with data integrity requirements of regulatory agencies.
The growth of biologics and biological therapeutics has introduced a number of challenges for analysis.
Unlike conventional small molecule therapeutics, biologics, which are complex, require advanced characterization.
These technologies help to analyze the structural heterogeneities of proteins, their aggregation and glycosylation, and the molecular interactions and stability of the product.
Regulatory authorities continue to focus on the analytical and data integrity of higher standards.
Though advanced technologies can assist laboratories with ongoing compliance, they must be implemented within the existing frameworks that have made significant investments.
Next generation analytical technology seamlessly incorporates quality controls into laboratory workflows.
Modern laboratories are integrating sustainable practices into analytical methodologies.
Manufacturers increasingly recognize that both sustainability and superior level analytical services can be provided.
The analytical laboratories of the future will be completely integrated environments, with communication between equipment, automation of workflows, and quality decisions supported by advanced predictive analytics.
Pharmaceutical companies will benefit greatly from the investment in these technologies that will improve the ease of regulatory compliance.
As the pharmaceutical industry improves its analytical methods and speeds up its processes, the emphasis on analytical excellence and capability will define competition in the industry.
The level of quality in pharmaceuticals is being revolutionized. With the innovative analytical technology available, all processes of drug development and manufacturing are undergoing this transformation. Organizations now have the benefit of advancements in high-resolution systems and intelligent automation, as well as the use of digital labs and the increasing integration of AI.
The evolution of these technologies in the last decade has made great strides, and now even more unimaginable projects are becoming a reality.
